2026 hasn't been a happy New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative territory. And Intuitive's latest quarterly results ...
Worldwide procedures (da Vinci and Ion combined) grew approximately 20% compared with the third quarter of 2024. Da Vinci procedures grew approximately 19% and Ion procedures grew approximately 52%.
Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results